Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 8-K Event Delisting notice
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Regulation FD disclosure
  4. 4 Open-market buy Director bought 100,000 shares at $0.50 ($49,630)
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Results of operations · Regulation FD disclosure · Other events
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. DEF 14A Proxy Proxy Statement
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 2 of 38 · 755 filings